BRPI0814202B1 - métodos e sistemas de determinação da concentração de produto de análise em amostra fluida - Google Patents
métodos e sistemas de determinação da concentração de produto de análise em amostra fluida Download PDFInfo
- Publication number
- BRPI0814202B1 BRPI0814202B1 BRPI0814202-5A BRPI0814202A BRPI0814202B1 BR PI0814202 B1 BRPI0814202 B1 BR PI0814202B1 BR PI0814202 A BRPI0814202 A BR PI0814202A BR PI0814202 B1 BRPI0814202 B1 BR PI0814202B1
- Authority
- BR
- Brazil
- Prior art keywords
- current
- concentration
- calibration curve
- time segment
- target range
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 67
- 239000012530 fluid Substances 0.000 title claims abstract description 49
- 238000011088 calibration curve Methods 0.000 claims abstract description 89
- 230000005284 excitation Effects 0.000 claims abstract description 40
- 238000004458 analytical method Methods 0.000 claims description 89
- 108090000790 Enzymes Proteins 0.000 claims description 9
- 102000004190 Enzymes Human genes 0.000 claims description 9
- 229940088598 enzyme Drugs 0.000 claims description 9
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 claims description 6
- 235000010299 hexamethylene tetramine Nutrition 0.000 claims description 6
- 239000004312 hexamethylene tetramine Substances 0.000 claims description 6
- VKYKSIONXSXAKP-UHFFFAOYSA-N hexamethylenetetramine Chemical compound C1N(C2)CN3CN1CN2C3 VKYKSIONXSXAKP-UHFFFAOYSA-N 0.000 claims description 6
- -1 potassium ferricyanide Chemical compound 0.000 claims description 6
- 229910052707 ruthenium Inorganic materials 0.000 claims description 6
- 108010050375 Glucose 1-Dehydrogenase Proteins 0.000 claims description 5
- 108010015776 Glucose oxidase Proteins 0.000 claims description 5
- 239000004366 Glucose oxidase Substances 0.000 claims description 5
- 229940116332 glucose oxidase Drugs 0.000 claims description 5
- 235000019420 glucose oxidase Nutrition 0.000 claims description 5
- 239000012491 analyte Substances 0.000 abstract description 47
- 238000012360 testing method Methods 0.000 description 120
- 239000000523 sample Substances 0.000 description 71
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 55
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 54
- 239000008103 glucose Substances 0.000 description 54
- 210000004369 blood Anatomy 0.000 description 43
- 239000008280 blood Substances 0.000 description 43
- 238000005259 measurement Methods 0.000 description 37
- 239000010410 layer Substances 0.000 description 34
- 238000005534 hematocrit Methods 0.000 description 28
- 238000001514 detection method Methods 0.000 description 20
- 239000003153 chemical reaction reagent Substances 0.000 description 17
- 239000000243 solution Substances 0.000 description 14
- 239000000470 constituent Substances 0.000 description 10
- 239000000306 component Substances 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- 230000008569 process Effects 0.000 description 7
- 230000000875 corresponding effect Effects 0.000 description 6
- 125000006850 spacer group Chemical group 0.000 description 6
- 239000012086 standard solution Substances 0.000 description 6
- 210000003743 erythrocyte Anatomy 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 210000001124 body fluid Anatomy 0.000 description 4
- 239000010839 body fluid Substances 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 230000001419 dependent effect Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 4
- 239000012790 adhesive layer Substances 0.000 description 3
- 230000002411 adverse Effects 0.000 description 3
- 239000004020 conductor Substances 0.000 description 3
- 230000002596 correlated effect Effects 0.000 description 3
- 238000002405 diagnostic procedure Methods 0.000 description 3
- 239000012777 electrically insulating material Substances 0.000 description 3
- 238000013213 extrapolation Methods 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 238000012544 monitoring process Methods 0.000 description 3
- 229920000728 polyester Polymers 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 210000003296 saliva Anatomy 0.000 description 3
- 238000005070 sampling Methods 0.000 description 3
- 230000001960 triggered effect Effects 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 2
- 238000005299 abrasion Methods 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 239000012503 blood component Substances 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 238000000840 electrochemical analysis Methods 0.000 description 2
- 238000003487 electrochemical reaction Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 2
- 239000008108 microcrystalline cellulose Substances 0.000 description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 description 2
- 229910000160 potassium phosphate Inorganic materials 0.000 description 2
- 235000011009 potassium phosphates Nutrition 0.000 description 2
- 238000006479 redox reaction Methods 0.000 description 2
- 230000027756 respiratory electron transport chain Effects 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- NECRQCBKTGZNMH-UHFFFAOYSA-N 3,5-dimethylhex-1-yn-3-ol Chemical compound CC(C)CC(C)(O)C#C NECRQCBKTGZNMH-UHFFFAOYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-N Gluconic acid Natural products OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000002210 biocatalytic effect Effects 0.000 description 1
- 239000010836 blood and blood product Substances 0.000 description 1
- 229940125691 blood product Drugs 0.000 description 1
- 230000006037 cell lysis Effects 0.000 description 1
- 230000012292 cell migration Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000012992 electron transfer agent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- YAGKRVSRTSUGEY-UHFFFAOYSA-N ferricyanide Chemical group [Fe+3].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] YAGKRVSRTSUGEY-UHFFFAOYSA-N 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 238000009532 heart rate measurement Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000007373 indentation Methods 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000006722 reduction reaction Methods 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 239000012453 solvate Substances 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 210000001138 tear Anatomy 0.000 description 1
- 238000006276 transfer reaction Methods 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 238000013022 venting Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/28—Electrolytic cell components
- G01N27/30—Electrodes, e.g. test electrodes; Half-cells
- G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
- G01N27/3271—Amperometric enzyme electrodes for analytes in body fluids, e.g. glucose in blood
- G01N27/3273—Devices therefor, e.g. test element readers, circuitry
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Electrochemistry (AREA)
- Physics & Mathematics (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Sampling And Sample Adjustment (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US95207607P | 2007-07-26 | 2007-07-26 | |
| PCT/US2008/071128 WO2009015316A1 (en) | 2007-07-26 | 2008-07-25 | System and methods for determination of analyte concentration using time resolved amperometry |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BRPI0814202A2 BRPI0814202A2 (pt) | 2015-01-27 |
| BRPI0814202B1 true BRPI0814202B1 (pt) | 2019-10-29 |
Family
ID=39951498
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0814202-5A BRPI0814202B1 (pt) | 2007-07-26 | 2008-07-25 | métodos e sistemas de determinação da concentração de produto de análise em amostra fluida |
| BRPI0814201-7A2A BRPI0814201A2 (pt) | 2007-07-26 | 2008-07-25 | Sistema e método de análise de produto de análise em amostra fluida e meio legível em computador |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0814201-7A2A BRPI0814201A2 (pt) | 2007-07-26 | 2008-07-25 | Sistema e método de análise de produto de análise em amostra fluida e meio legível em computador |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US8088272B2 (enExample) |
| EP (2) | EP2176653B1 (enExample) |
| JP (2) | JP5604298B2 (enExample) |
| AT (1) | ATE523777T1 (enExample) |
| AU (2) | AU2008279067A1 (enExample) |
| BR (2) | BRPI0814202B1 (enExample) |
| MX (3) | MX2010000971A (enExample) |
| TW (2) | TW200916774A (enExample) |
| WO (2) | WO2009015316A1 (enExample) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2006132051A (ru) | 2004-02-06 | 2008-03-20 | БАЙЕР ХЕЛТКЭР ЭлЭлСи (US) | Окисляемые соединения в качестве внутреннего стандарта для биосенсоров и способ их применения |
| AU2006297572B2 (en) | 2005-09-30 | 2012-11-15 | Ascensia Diabetes Care Holdings Ag | Gated Voltammetry |
| EP2176653B1 (en) | 2007-07-26 | 2011-09-07 | Nipro Diagnostics, Inc. | System and methods for determination of analyte concentration using time resolved amperometry |
| US8101062B2 (en) * | 2007-07-26 | 2012-01-24 | Nipro Diagnostics, Inc. | System and methods for determination of analyte concentration using time resolved amperometry |
| RU2491549C2 (ru) * | 2007-12-10 | 2013-08-27 | БАЙЕР ХЕЛТКЭА ЭлЭлСи | Амперометрия со стробированием и быстрым считыванием |
| WO2009076302A1 (en) | 2007-12-10 | 2009-06-18 | Bayer Healthcare Llc | Control markers for auto-detection of control solution and methods of use |
| JP2009272996A (ja) * | 2008-05-09 | 2009-11-19 | Toshiba Corp | 携帯端末 |
| WO2010006253A1 (en) | 2008-07-10 | 2010-01-14 | Bayer Healthcare Llc | Systems and methods including amperometric and voltammetric duty cycles |
| ATE546730T1 (de) * | 2008-11-26 | 2012-03-15 | Atotech Deutschland Gmbh | Verfahren zur kontrolle von stabilisatoradditiven in elektrolyten zur chemischen metall- und metalllegierungsabscheidung |
| JP2010261895A (ja) * | 2009-05-11 | 2010-11-18 | Emiko Kaneko | 溶液中微量成分の濃度測定方法及び濃度測定装置 |
| US8173008B2 (en) * | 2009-06-24 | 2012-05-08 | Lifescan, Inc. | Method for determining an analyte in a bodily fluid sample using an analyte test strip with combination electrode contact and meter identification feature |
| US20100326824A1 (en) * | 2009-06-24 | 2010-12-30 | Lifescan, Inc. | Analyte test strip with combination electrode contact and meter identification feature |
| US8101065B2 (en) | 2009-12-30 | 2012-01-24 | Lifescan, Inc. | Systems, devices, and methods for improving accuracy of biosensors using fill time |
| US8877034B2 (en) * | 2009-12-30 | 2014-11-04 | Lifescan, Inc. | Systems, devices, and methods for measuring whole blood hematocrit based on initial fill velocity |
| KR101929057B1 (ko) * | 2010-03-22 | 2018-12-13 | 바이엘 헬쓰케어 엘엘씨 | 바이오센서를 위한 잔여 보상 |
| JP5785247B2 (ja) * | 2010-03-31 | 2015-09-24 | ライフスキャン・スコットランド・リミテッド | 電気化学的な分析物測定法及びシステム |
| BR112013005442A2 (pt) | 2010-09-13 | 2016-05-17 | Lifescan Scotland Ltd | método de medição de analito e sistema com compensação de hematócrito |
| US8617370B2 (en) | 2010-09-30 | 2013-12-31 | Cilag Gmbh International | Systems and methods of discriminating between a control sample and a test fluid using capacitance |
| US8932445B2 (en) | 2010-09-30 | 2015-01-13 | Cilag Gmbh International | Systems and methods for improved stability of electrochemical sensors |
| WO2012084194A1 (en) | 2010-12-22 | 2012-06-28 | Roche Diagnostics Gmbh | Systems and methods to compensate for sources of error during electrochemical testing |
| EP2696763A4 (en) * | 2011-04-14 | 2015-03-04 | Isense Acquisition Llc | CONTAMINATION DETECTION ON SENSOR CONTACTS |
| EP3315123B1 (en) | 2011-09-21 | 2019-08-21 | Ascensia Diabetes Care Holdings AG | Analysis compensation including segmented signals |
| US8534115B2 (en) * | 2011-10-17 | 2013-09-17 | Schlumberger Technology Corporation | Systems and methods of determining parameter values in a downhole environment |
| US9636044B2 (en) * | 2012-02-01 | 2017-05-02 | Invoy Technologies, Llc | Breath analyzer with expandable range of measurement |
| US10327685B2 (en) * | 2012-12-20 | 2019-06-25 | Becton, Dickinson And Company | System and method for using multiple sensor calibration methods |
| GB201511299D0 (en) * | 2015-06-26 | 2015-08-12 | Inside Biometrics Ltd | Test device and method of using a test device |
| WO2019036586A1 (en) * | 2017-08-18 | 2019-02-21 | Diversey, Inc. | Solution concentration sensing devices |
| CA3081401A1 (en) * | 2017-10-30 | 2019-05-09 | The Regents Of The University Of California | Calibration free in-vivo measurement of analytes using electrochemical sensors |
| EP4408278B1 (en) * | 2021-09-27 | 2026-03-18 | Medtrum Technologies Inc. | Analyte detection system |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6279159U (enExample) * | 1985-11-07 | 1987-05-20 | ||
| JPH0672845B2 (ja) * | 1986-09-01 | 1994-09-14 | 富士写真フイルム株式会社 | 分析方法 |
| US5352351A (en) | 1993-06-08 | 1994-10-04 | Boehringer Mannheim Corporation | Biosensing meter with fail/safe procedures to prevent erroneous indications |
| US6153069A (en) * | 1995-02-09 | 2000-11-28 | Tall Oak Ventures | Apparatus for amperometric Diagnostic analysis |
| AUPN661995A0 (en) * | 1995-11-16 | 1995-12-07 | Memtec America Corporation | Electrochemical cell 2 |
| JPH09292387A (ja) * | 1996-04-25 | 1997-11-11 | Kdk Corp | 被測定成分量の測定方法及び被測定成分量の測定装置 |
| US5997817A (en) * | 1997-12-05 | 1999-12-07 | Roche Diagnostics Corporation | Electrochemical biosensor test strip |
| US6251260B1 (en) * | 1998-08-24 | 2001-06-26 | Therasense, Inc. | Potentiometric sensors for analytic determination |
| US6475372B1 (en) * | 2000-02-02 | 2002-11-05 | Lifescan, Inc. | Electrochemical methods and devices for use in the determination of hematocrit corrected analyte concentrations |
| US6424847B1 (en) * | 1999-02-25 | 2002-07-23 | Medtronic Minimed, Inc. | Glucose monitor calibration methods |
| US7276146B2 (en) * | 2001-11-16 | 2007-10-02 | Roche Diagnostics Operations, Inc. | Electrodes, methods, apparatuses comprising micro-electrode arrays |
| US20060091006A1 (en) * | 1999-11-04 | 2006-05-04 | Yi Wang | Analyte sensor with insertion monitor, and methods |
| CN100346158C (zh) * | 2000-11-30 | 2007-10-31 | 松下电器产业株式会社 | 基质的定量方法 |
| WO2003000127A2 (en) * | 2001-06-22 | 2003-01-03 | Cygnus, Inc. | Method for improving the performance of an analyte monitoring system |
| WO2003036285A1 (en) * | 2001-10-26 | 2003-05-01 | Arkray, Inc. | Specific component concentration measuring method and concentration measuring instrument |
| US7018843B2 (en) * | 2001-11-07 | 2006-03-28 | Roche Diagnostics Operations, Inc. | Instrument |
| KR100475634B1 (ko) * | 2001-12-24 | 2005-03-15 | 주식회사 아이센스 | 일정 소량의 시료를 빠르게 도입할 수 있는 시료도입부를구비한 바이오 센서 |
| US6863800B2 (en) * | 2002-02-01 | 2005-03-08 | Abbott Laboratories | Electrochemical biosensor strip for analysis of liquid samples |
| ES2357318T3 (es) * | 2002-03-22 | 2011-04-25 | Animas Technologies Llc | Mejora del rendimiento de un dispositivo monitorizador de analito. |
| KR100729307B1 (ko) | 2002-06-17 | 2007-06-15 | 아크레이 인코퍼레이티드 | 글루코스 탈수소효소를 이용한 글루코스 농도 측정방법 및글루코스 센서 |
| CN101561410B (zh) * | 2002-11-01 | 2012-10-03 | 爱科来株式会社 | 测量用具 |
| AU2006279579A1 (en) * | 2005-08-16 | 2007-02-22 | Home Diagnostics, Inc. | Method for test strip manufacturing and analysis |
| EP1927850B1 (en) * | 2005-09-14 | 2015-04-15 | Sumitomo Electric Industries, Ltd. | Bio-sensor measuring device, bio-sensor measuring system, and bio-sensor measuring method |
| US7749371B2 (en) * | 2005-09-30 | 2010-07-06 | Lifescan, Inc. | Method and apparatus for rapid electrochemical analysis |
| US20080020452A1 (en) * | 2006-07-18 | 2008-01-24 | Natasha Popovich | Diagnostic strip coding system with conductive layers |
| US7822557B2 (en) | 2006-10-31 | 2010-10-26 | Abbott Diabetes Care Inc. | Analyte sensors and methods |
| US20090007947A1 (en) * | 2006-12-22 | 2009-01-08 | Angela Spangenberg | Portable weather shielding canopy |
| US20090026094A1 (en) * | 2007-05-11 | 2009-01-29 | Home Diagnostics, Inc. | Two-pulse systems and methods for determining analyte concentration |
| EP2176653B1 (en) | 2007-07-26 | 2011-09-07 | Nipro Diagnostics, Inc. | System and methods for determination of analyte concentration using time resolved amperometry |
| US8101062B2 (en) * | 2007-07-26 | 2012-01-24 | Nipro Diagnostics, Inc. | System and methods for determination of analyte concentration using time resolved amperometry |
-
2008
- 2008-07-25 EP EP08796603A patent/EP2176653B1/en not_active Not-in-force
- 2008-07-25 MX MX2010000971A patent/MX2010000971A/es active IP Right Grant
- 2008-07-25 MX MX2010000972A patent/MX2010000972A/es not_active Application Discontinuation
- 2008-07-25 JP JP2010518401A patent/JP5604298B2/ja active Active
- 2008-07-25 WO PCT/US2008/071128 patent/WO2009015316A1/en not_active Ceased
- 2008-07-25 TW TW097128397A patent/TW200916774A/zh unknown
- 2008-07-25 AU AU2008279067A patent/AU2008279067A1/en not_active Abandoned
- 2008-07-25 AT AT08796603T patent/ATE523777T1/de not_active IP Right Cessation
- 2008-07-25 JP JP2010518403A patent/JP5179583B2/ja active Active
- 2008-07-25 TW TW097128393A patent/TWI453401B/zh active
- 2008-07-25 BR BRPI0814202-5A patent/BRPI0814202B1/pt active IP Right Grant
- 2008-07-25 EP EP08796601.6A patent/EP2176652B1/en active Active
- 2008-07-25 AU AU2008279070A patent/AU2008279070B2/en not_active Expired - Fee Related
- 2008-07-25 WO PCT/US2008/071132 patent/WO2009015319A1/en not_active Ceased
- 2008-07-25 US US12/179,853 patent/US8088272B2/en active Active
- 2008-07-25 US US12/179,870 patent/US20090076738A1/en not_active Abandoned
- 2008-07-25 BR BRPI0814201-7A2A patent/BRPI0814201A2/pt active Search and Examination
-
2010
- 2010-01-25 MX MX2013002928A patent/MX340856B/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2010534838A (ja) | 2010-11-11 |
| MX340856B (es) | 2016-07-28 |
| US20090076738A1 (en) | 2009-03-19 |
| ATE523777T1 (de) | 2011-09-15 |
| EP2176653B1 (en) | 2011-09-07 |
| US20090101523A1 (en) | 2009-04-23 |
| EP2176652B1 (en) | 2014-04-23 |
| EP2176652A1 (en) | 2010-04-21 |
| TW200916774A (en) | 2009-04-16 |
| TWI453401B (zh) | 2014-09-21 |
| AU2008279067A1 (en) | 2009-01-29 |
| WO2009015316A1 (en) | 2009-01-29 |
| TW200914820A (en) | 2009-04-01 |
| JP2010534839A (ja) | 2010-11-11 |
| BRPI0814202A2 (pt) | 2015-01-27 |
| BRPI0814201A2 (pt) | 2015-01-27 |
| JP5179583B2 (ja) | 2013-04-10 |
| JP5604298B2 (ja) | 2014-10-08 |
| EP2176653A1 (en) | 2010-04-21 |
| MX2010000972A (es) | 2010-03-01 |
| AU2008279070A1 (en) | 2009-01-29 |
| MX2010000971A (es) | 2010-03-01 |
| WO2009015319A1 (en) | 2009-01-29 |
| US8088272B2 (en) | 2012-01-03 |
| AU2008279070B2 (en) | 2012-12-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0814202B1 (pt) | métodos e sistemas de determinação da concentração de produto de análise em amostra fluida | |
| US8574424B2 (en) | System and methods for determination of analyte concentration using time resolved amperometry | |
| US9347910B2 (en) | Systems and methods for improved stability of electrochemical sensors | |
| US8080153B2 (en) | Analyte determination methods and devices | |
| US20120111739A1 (en) | Dual Frequency Impedance Measurement of Hematocrit in Strips | |
| US20090026094A1 (en) | Two-pulse systems and methods for determining analyte concentration | |
| US20130118920A1 (en) | Systems and methods for improved accuracy for temperature correction of glucose results for control solution | |
| BR112012004976A2 (pt) | Método e sistema para medição de glicose |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B25D | Requested change of name of applicant approved |
Owner name: NIPRO DIAGNOSTICS, INC. (US) |
|
| B25F | Entry of change of name and/or headquarter and transfer of application, patent and certif. of addition of invention: change of name on requirement |
Owner name: NIPRO DIAGNOSTICS, INC. (US) |
|
| B25D | Requested change of name of applicant approved |
Owner name: TRIVIDIA HEALTH, INC. (US) |
|
| B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 29/10/2019, OBSERVADAS AS CONDICOES LEGAIS. (CO) 10 (DEZ) ANOS CONTADOS A PARTIR DE 29/10/2019, OBSERVADAS AS CONDICOES LEGAIS |